Education
About Us
Working with TipRanks
Follow Us
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -551.00K | $ -571.00K | $ -1.81M | $ -685.00K | $ -209.00K |
| Operating Income | $ -31.66M | $ -37.06M | $ -49.12M | $ -37.48M | $ -19.45M |
| EBITDA | $ -29.52M | $ -33.39M | $ -46.56M | $ -35.44M | $ -18.20M |
| Net Income | $ -30.16M | $ -34.10M | $ -48.59M | $ -36.79M | $ -20.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 41.34M | $ 65.76M | $ 107.12M | $ 147.62M | $ 16.60M |
| Total Assets | $ 45.36M | $ 74.37M | $ 118.38M | $ 153.22M | $ 21.43M |
| Total Debt | $ 3.85M | $ 6.21M | $ 8.03M | $ 2.35M | $ 685.00K |
| Net Debt | $ -6.15M | $ -6.80M | $ -9.76M | $ -4.80M | $ -15.91M |
| Total Liabilities | $ 6.97M | $ 9.48M | $ 14.97M | $ 6.71M | $ 5.54M |
| Stockholders' Equity | $ 38.39M | $ 64.89M | $ 103.41M | $ 146.51M | $ 15.89M |
| Cash Flow | |||||
| Free Cash Flow | $ -24.82M | $ -32.20M | $ -39.35M | $ -32.28M | $ -18.91M |
| Operating Cash Flow | $ -24.67M | $ -32.02M | $ -39.03M | $ -30.26M | $ -17.70M |
| Investing Cash Flow | $ 22.44M | $ 38.41M | $ 49.95M | $ -143.12M | $ -1.40M |
| Financing Cash Flow | $ -787.00K | $ -11.17M | $ -287.00K | $ 163.94M | $ 35.45M |